Telomerase inhibitors

Trends in Biotechnology

Volumn 19, Issue 3, 2001, Pages 114-120

  White, Laura K ^a   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIAMIDOANTHRAQUINONE; ACRIDINE DERIVATIVE; ANGIOGENESIS INHIBITOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA; FLUORENONE DERIVATIVE; MESSENGER RNA; PORPHYRIN DERIVATIVE; QUINONE DERIVATIVE; RIBOZYME; RNA DIRECTED DNA POLYMERASE INHIBITOR; TELOMERASE; TELOMERASE INHIBITOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADJUVANT THERAPY; CANCER; CANCER THERAPY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOTECHNOLOGY; CELL AGING; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; HUMANS; IMMUNOTHERAPY; MODELS, BIOLOGICAL; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE INHIBITORS; RNA, CATALYTIC; TELOMERASE; TELOMERE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035283512     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(00)01541-9     Document Type: Review

References (38)

1. Haylick, his limit, and cellular aging
2. A role for both RB and p53 in the regulation of human cellular senescence
3. The two-stage mechanism controlling cellular senescence and immortalization
4. Specific association of human telomerase activity with immortal cells and cancer
5. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts
6. The RNA component of human telomerase
7. Telomere elongation in immortal human cells without detectable telomerase activity
8. Telomerase activity in human germline and embryonic tissues and cells
9. Mice without telomerase: What can they teach us about human cancer?
10. Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology
11. Antisense oligonucleotides as therapeutic agents
12. Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro
13. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotide
14. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
15. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo
16. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
17. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells
18. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
19. Inhibition of human telomerase activity by peptide nucleic acids
20. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells
21. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
22. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells
23. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells
24. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
25. Inhibition of telomerase limits the growth of human cancer cells
26. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortal human cell lines
27. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine
28. Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines
29. Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine (AZT) treatment
30. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
31. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
32. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
33. Human telomerase inhibition by substituted acridine derivatives
34. Inhibition of human telomerase by a G-quadruplex-interactive compound
35. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase
36. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships
37. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm
38. FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis